SUMO: a novel target for anti-coronavirus therapy

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Severe acute respiratory syndrome-associated coronavirus (SARS-CoV), Middle East respiratory syndrome-associated coronavirus (MERS-CoV), and coronavirus disease 2019 (COVID-19) are three major coronavirus outbreaks in the last 20 years.
• COVID-19 has caused a global health and economic crisis, necessitating the development of effective treatments.
• The small ubiquitin-like modifier (SUMO) system's role in coronavirus infections remains largely unexplored.

Purpose of the Study:

• To review recent findings on the involvement of the host SUMO system in coronavirus infections.
• To highlight the potential of the SUMO system as a therapeutic target for combating coronaviruses.
• To emphasize the need for further research into coronavirus pathology for future outbreak preparedness.

Main Methods:

• Literature review of recently published studies.
• Analysis of data on the interaction between host SUMOylation pathways and coronavirus replication.
• Synthesis of information regarding the impact of SUMO on viral pathogenesis.

Main Results:

• Evidence suggests the host SUMO system plays a role in facilitating coronavirus replication and pathogenesis.
• SUMOylation of viral or host proteins appears to be a common mechanism exploited by coronaviruses.
• Specific SUMOylation targets and their functional consequences are beginning to be elucidated.

Conclusions:

• The host SUMO system represents a promising novel target for developing anti-coronavirus therapies.
• A deeper understanding of SUMO's role in coronavirus infection is crucial for effective treatment strategies.
• Targeting host-virus interactions, such as SUMOylation, may be key to controlling current and future coronavirus outbreaks.